Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making.

Related Articles

Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making.

Open Biochem J. 2013;7:24-32

Authors: Mian AI, Aranke M, Bryan NS

Abstract
The potential of nitric oxide (NO) as a rapid assay biomarker, one that could provide a quantum leap in acute care, remains largely untapped. NO plays a crucial role as bronchodilator, vasodilator and inflammatory mediator. The main objective of this review is to demonstrate how NO is a molecule of heavy interest in various acute disease states along the emergency department and critical care spectrum: respiratory infections, central nervous system infections, asthma, acute kidney injury, sepsis, septic shock, and myocardial ischemia, to name just a few. We discuss how NO and its oxidative metabolites, nitrite and nitrate, are readily detectable in several body compartments and fluids, and as such they are associated with many of the pathophysiological processes mentioned above. With methods such as high performance liquid chromatography and chemiluminescence these entities are relatively easy and inexpensive to analyze. Emphasis is placed on diagnostic rapidity, as this relates directly to quality of care in acute care situations. Further, a rationale is provided for more bench, translational and clinical research in the field of NO biomarkers for such settings. Developing standard protocols for the aforementioned disease states, centered on concentrations of NO and its metabolites, can prove to revolutionize diagnostics and prognostication along a spectrum of clinical care. We present a strong case for developing these biomarkers more as point-of-care assays with potential of color gradient test strips for rapid screening of disease entities in acute care and beyond. This will be relevant to global health.

PMID: 23539501 [PubMed – in process]

View full post on pubmed: asthma

Personalized asthma monitor uses nanotechnology to detect biomarkers in the … – Nanowerk LLC


Nanowerk LLC

Personalized asthma monitor uses nanotechnology to detect biomarkers in the
Nanowerk LLC
(Nanowerk News) An interdisciplinary team of Stony Brook University researchers have been selected to receive a three year National Science Foundation (NSF) award for the development of a personalized asthma monitor that uses nanotechnology to detect

and more »

View full post on asthma – Google News

Novel biomarkers may aid in diagnosis and management of asthma, COPD – News-Medical.net

Novel biomarkers may aid in diagnosis and management of asthma, COPD
News-Medical.net
Four novel biomarkers have been identified which may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease (COPD), according to a study conducted by researchers in Australia, who determined the biomarkers may be used

and more »

View full post on asthma – Google News

Four novel biomarkers that may help diagnose asthma, COPD identified – Sify

Four novel biomarkers that may help diagnose asthma, COPD identified
Sify
Researchers in Australia have identified four novel biomarkers that may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease (COPD). According to a study the biomarkers may be used in different combinations to
New Technique May Help Diagnose Asthma, COPDWebMD
Biomarker Panel Identifies Asthma, COPDMedscape
Researchers link novel biomarkers to asthma and COPDEurekAlert (press release)

all 10 news articles »

View full post on asthma – Google News